Article | January 1, 2022

Quantify And Characterize Host Cell Protein With Confidence

Source: Cytiva
iStock-861606270-scientist-lab-DNA

Chinese hamster ovary (CHO) cells are a widely used system to produce recombinant proteins via cell culture, but this approach has a major caveat: these host cells also produce various proteins to support normal cell growth, survival and proliferation.

These host cell proteins (HCPs) pose a risk for immunogenicity of biotherapeutic products and must be reduced to sufficiently low levels to ensure safety and efficacy. Relying on inadequate HCP detection methods can create additional costs and significant project delays, as the discovery of unexpected HCP levels in later clinical trial phases necessitates a redesign of the purification strategy.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online